Search Results - "BECHAR, Naftali"

Primary mFOLFOX6 Plus Bevacizumab Without Resection of the Primary Tumor for Patients Presenting With Surgically Unresectable Metastatic Colon Cancer and an Intact Asymptomatic Colon Cancer: Definitive Analysis of NSABP Trial C-10 by MCCAHILL, Laurence E, YOTHERS, Greg, WAGMAN, Lawrence D, O'CONNELL, Michael J, WOLMARK, Norman, SHARIF, Saima, PETRELLI, Nicholas J, LAI, Lily Lau, BECHAR, Naftali, GIGUERE, Jeffrey K, DAKHIL, Shaker R, FEHRENBACHER, Louis, LOPA, Samia H

“…Major concerns surround combining chemotherapy with bevacizumab in patients with colon cancer presenting with an asymptomatic intact primary tumor (IPT) and…”
Get full text

A pilot study of long-acting octreotide for symptomatic malignant ascites by Jatoi, Aminah, Nieva, Jorge J, Qin, Rui, Loprinzi, Charles L, Wos, Edward J, Novotny, Paul J, Moore, Jr, Dennis F, Mowat, Rex B, Bechar, Naftali, Pajon, Jr, Eduardo R, Hartmann, Lynn C

“…Effective, non-invasive, palliative strategies for symptomatic malignant ascites are unavailable. This trial explored whether octreotide, an inhibitor of…”
Get more information

Phase 1b study of RGX-202-01, a first-in-class oral inhibitor of the SLC6A8/CKB pathway, in combination with FOLFIRI and bevacizumab (BEV) in second-line advanced colorectal cancer (CRC) by Hendifar, Andrew Eugene, Rosen, Lee S., Cercek, Andrea, McRee, Autumn Jackson, Basu Mallick, Atrayee, Spigel, David R., Tavazoie, Sohail F, Rowinsky, Eric Keith, Szarek, Michael, Gonsalves, Foster, Kurth, Isabel, Andreu, Celia, Busby, Robert, Spector, Scott, Darst, David Martin, Lebaka, Narayan, Bechar, Naftali, Tavazoie, Masoud, Wasserman, Robert, Fakih, Marwan

“…3579 Background: A proprietary in vivo target discovery screen identified creatine kinase-B (CKB) as a cancer driver in KRAS mutant (KRAS-mut) CRC. CKB…”
Get full text

Paclitaxel plus bevacizumab in patients with chemosensitive relapsed small cell lung cancer: a safety, feasibility, and efficacy study from the Hoosier Oncology Group by Jalal, Shadia, Bedano, Pablo, Einhorn, Lawrence, Bhatia, Sumeet, Ansari, Rafat, Bechar, Naftali, Koneru, Karuna, Govindan, Ramaswamy, Wu, Jingwei, Yu, Menggang, Schneider, Bryan, Hanna, Nasser

“…Bevacizumab when combined with carboplatin and paclitaxel improves response rates (RRs) and overall survival in patients with advanced non-small cell lung…”
Get more information

Basic steps to building a research program by Baer, Allison, Bechar, Naftali, Cohen, Gary, Devine, Susan

“…Establishing a clinical trial infrastructure is an important step when developing a successful research program. Two areas required for success include…”
Get full text